The IMS remains focused on providing support and educational tools to help oncologists and hematologists world-wide choose optimal treatments for their myeloma patients.
To learn more about how we achieve these aims, please explore this section of our site. This page will be updated to reflect upcoming events and new developments.
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.